BSTZ
Get informed when a big investor buys or sells
+ FollowOvervalued by 98.8% based on the discounted cash flow analysis.
| Market cap | $2.10 Billion |
|---|---|
| Enterprise Value | $2.11 Billion |
| Dividend Yield | $2.71 (8.48%) |
| Earnings per Share | $4.57 |
| Beta | 1.48 |
| Outstanding Shares | 68,744,150 |
| P/E Ratio | 6.87 |
|---|---|
| PEG | 4.68 |
| Price to Sales | 5.98 |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | 5.31 |
| Enterprise Value to EBIT | 3.57 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 31.95%▲ 1.37% |
|---|---|
| Total Invested | $659.06M▲ 41.63% |
| Investors Holding | 151▲ 19.00% |
No data
BlackRock Science and Technology Trust II, is a limited-term closed-end equity fund. BSTZ commenced operations in June 2019 with the investment objectives of providing total return and income through a combination of current income, curr...